Portfolio company
TwoStep Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pep-Therapy
This biotechnology company develops intracellular peptide-based targeted therapies to treat patients with advanced solid tumours, including pancreatic and ovarian cancers.
Valink Therapeutics
Valink Therapeutics develops next-generation bispecific antibody-drug conjugates to treat solid tumours for cancer patients.
DualTPharma
This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.
Pheon Therapeutics
The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.
Theolytics
The company develops oncolytic viral immunotherapies for patients with solid tumours.
Callio Therapeutics
The company develops multi-payload antibody-drug conjugates to treat cancer patients.
Clinical stage immunotherapy company
This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.